Skip to main content
Search
Search This Blog
Biopharma Over Coffee
Weekly bites on recent goings on in the pharma, biotech and healthcare sectors.
Posts
Showing posts from 2024
Show all
November 29, 2024
Turning Setbacks into Strategies: Lessons from RELYVIRO’s journey in ALS
October 14, 2024
Medicamentos modificadores de la enfermedad para el Parkinson: ¿una nueva ola en el horizonte?
October 03, 2024
Disease-Modifying Drugs for Parkinson's Disease: A New Wave on the Horizon?
September 21, 2024
Changes in Market Access in Europe and Implications for Clinical Development Planning: Joint Clinical Assessments
August 09, 2024
Breaking Barriers: TECELRA Becomes the First Engineered T-Cell Therapy for Solid Tumors
August 01, 2024
La Reforma Farmacéutica de la UE en el punto de mira: implicaciones para la innovación y el acceso
Newer Posts
Older Posts
Home
